News

HER2+ Breast Ca Mortality Is Lowered With Trastuzumab

Publish date: August 1, 2006
PDF Download

 

Trial sponsor Roche markets trastuzumab internationally and has a majority interest in Genentech Inc., which markets the drug in the United States.

Pages

Recommended Reading

Weigh Fetal Exposure Risks Against Undertreatment
MDedge Family Medicine
Contraceptive Gel Appears Safer Than Nonoxynol-9 : Cellulose sulfate, an experimental vaginal gel, is reported effective in preventing HIV, pregnancy.
MDedge Family Medicine
Vaginal Cytology Deemed a Poor Endometrial Ca Screen
MDedge Family Medicine
Intervening in Pregnancy Can Curb Depression
MDedge Family Medicine
Double Decidual Sign Rules Out Ectopic Pregnancy
MDedge Family Medicine
Most First-Time Mothers Wouldn't Choose Elective Cesarean Again
MDedge Family Medicine
New Glycemic Control Targets In Pregnancy May Be Needed
MDedge Family Medicine
Low Vitamin D Tied to Bone Loss in Breast Cancer
MDedge Family Medicine
Yoga Boosts Quality of Life During Breast Ca Radiation
MDedge Family Medicine
Physical Activity Reduces Cancer Risk in Postmenopausal Women
MDedge Family Medicine